To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.
To help HKAPI members understand more about the operation of DHC and opportunities for the pharmaceutical industry, the Public-Private Partnership task force organized a Sharing Session on April 27, 2022.
The Regulatory Training Workshop Series held from February to March 2022 concluded successfully.
Dr Daniel Lee of the Chinese University of Hong Kong, introduced the first ATP GMP facility in Hong Kong to our members.
The Affordability Task Force and PPP Task Force co-organized a sharing session for members about Drug Affordability.